
News|Articles|October 1, 2006
Valsartan appears more effective than amlodipine in preventing HF, diabetes in patients with hypertension
An angiotensin receptor blocker (ARB) valsartan-based regimen offered advantages over a calcium channel blocker (CCB) amlodipine-based regimen in preventing heart failure (HF) and diabetes in patients with hypertension, according to results of an analysis published in Hypertension.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Judi Health, Employers Health team up to launch new PBM solution
2
Growth of GLP-1 therapies has reshaped the market | PBMI 2026
3
Brandon Kessler on pharmacy pricing under CAA 2026 | PBMI 2026
4
Amy Wadstrom, RPh, on mid-size PBMs and leaving the ‘big three’ | PBMI 2026
5























